Physician profile
John Francis
NPI 1578906574
$3,966.28
in general payments reported to CMS, 2019-2025
42 companies · $1,843 in 2025
The $1,843 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $270 · 2021: $103 · 2022: $165 · 2023: $574 · 2024: $564 · 2025: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128 · Travel and Lodging: $814 · Education: $38.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.72 |
| Travel and Lodging | $814.27 |
| Education | $38.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,335.71 | 2019-2025 | Lumenis Pulse 120h, Moses |
| Sumitomo Pharma America, INC. | $286.94 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $243.20 | 2019-2024 | |
| Coloplast Corp | $196.71 | 2019-2021 | |
| Axonics, INC. | $152.37 | 2023-2024 | Axonics, Bulkamid |
| 180 Medical, INC. | $146.56 | 2020-2025 | |
| Pfizer INC. | $132.88 | 2023-2025 | |
| Janssen Biotech, INC. | $121.71 | 2019-2022 | |
| Accord Healthcare, INC. | $106.80 | 2023-2024 | |
| Urogen Pharma, INC. | $75.26 | 2023-2025 | Jelmyto |
| Antares Pharma, INC. | $73.75 | 2024-2025 | Xyosted |
| Endo Pharmaceuticals INC. | $73.28 | 2019-2023 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $66.93 | 2023-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $63.08 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $61.89 | 2025 | Adstiladrin |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $60.38 | 2024-2025 | Bard Urinary Drainage Bag |
| Alnylam Pharmaceuticals INC. | $57.39 | 2023 | Oxlumo, Givlaari |
| Medtronic, INC. | $56.85 | 2023-2025 | Interstim |
| Neotract INC. | $53.37 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $52.83 | 2019-2024 | Provenge |
| Astellas Pharma US INC | $50.61 | 2019-2025 | Xtandi |
| Calyxo, INC. | $45.74 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $39.29 | 2020-2025 | |
| Karl Storz Endoscopy-America | $39.23 | 2022 | |
| Healthtronics Stone Solutions, LLC | $34.06 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Koelis INC. | $27.62 | 2023 | |
| Photocure INC | $26.10 | 2020-2024 | Cysview |
| Myovant Sciences INC. | $25.38 | 2021 | |
| Endo USA, INC. | $24.65 | 2024 | Xiaflex |
| Blue Earth Diagnostics | $24.30 | 2020 | |
| Urovant Sciences INC | $21.42 | 2022 | |
| Integra Lifesciences Corporation | $21.07 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Verity Pharmaceuticals INC. | $20.93 | 2025 | Trelstar |
| Solventum Corporation | $19.86 | 2024 | Prevena, 3m Cavilon, V.A.C. Veraflo Cleanse Choice |
| Merck Sharp & Dohme LLC | $19.45 | 2025 | Keytruda |
| Abbvie INC. | $18.18 | 2025 | |
| Myriad Genetic Laboratories, INC. | $17.52 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.12 | 2025 | |
| Olympus America INC. | $15.74 | 2025 | Soltive |
| Convatec INC. | $15.69 | 2021 | |
| Conmed Corporation | $13.79 | 2022 | |
| Sagent Pharmaceuticals | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.